Bank Of America Sees Significant Manufacturing Capacity Expansions Underway For Pacira Pharmaceuticals

By: via Benzinga
In a report published Wednesday, Bank of America analyst Steve Byrne reiterated a Buy rating and $105.00 price target on Pacira ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.